Asterias Biotherapeutics Stock Return On Asset
Asterias Biotherapeutics fundamentals help investors to digest information that contributes to Asterias Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Asterias Stock. The fundamental analysis module provides a way to measure Asterias Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asterias Biotherapeutics stock.
Asterias |
Asterias Biotherapeutics Company Return On Asset Analysis
Asterias Biotherapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Asterias Biotherapeutics Return On Asset | -0.68 |
Most of Asterias Biotherapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asterias Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Asterias Biotherapeutics has a Return On Asset of -0.6763. This is 92.27% lower than that of the sector and 97.13% lower than that of the Return On Asset industry. The return on asset for all United States stocks is notably higher than that of the company.
Asterias Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asterias Biotherapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asterias Biotherapeutics could also be used in its relative valuation, which is a method of valuing Asterias Biotherapeutics by comparing valuation metrics of similar companies.Asterias Biotherapeutics is currently under evaluation in return on asset category among its peers.
Asterias Fundamentals
| Return On Equity | -93.17 | |||
| Return On Asset | -0.68 | |||
| Profit Margin | (4.60) % | |||
| Current Valuation | 40.31 M | |||
| Shares Outstanding | 55.66 M | |||
| Shares Owned By Insiders | 40.33 % | |||
| Shares Owned By Institutions | 13.75 % | |||
| Number Of Shares Shorted | 409.74 K | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 67.77 X | |||
| Revenue | 731 K | |||
| Gross Profit | 3.88 M | |||
| EBITDA | (41.26 M) | |||
| Net Income | (20.3 M) | |||
| Cash And Equivalents | 12.59 M | |||
| Cash Per Share | (0.61) X | |||
| Total Debt | 16 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 6.50 X | |||
| Book Value Per Share | 1.16 X | |||
| Cash Flow From Operations | (15.82 M) | |||
| Short Ratio | 2.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Number Of Employees | 31 | |||
| Beta | 3.73 | |||
| Market Capitalization | 52.6 M | |||
| Total Asset | 66.98 M | |||
| Retained Earnings | (59.85 M) | |||
| Working Capital | 19.54 M | |||
| Current Asset | 29.79 M | |||
| Current Liabilities | 10.25 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Asterias Stock
If you are still planning to invest in Asterias Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asterias Biotherapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |